No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs558668668 |
chr15:30920628-30920629 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs574728609 |
chr15:30920677-30920678 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs535007250 |
chr15:30920686-30920687 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs555271380 |
chr15:30920714-30920715 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs575100972 |
chr15:30920718-30920719 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs80068880 |
chr15:30920743-30920744 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs373846023 |
chr15:30920830-30920831 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs142722356 |
chr15:30920868-30920869 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs372584236 |
chr15:30920882-30920883 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs28733411 |
chr15:30920919-30920920 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs545824841 |
chr15:30921004-30921005 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs559097677 |
chr15:30921048-30921049 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs139834801 |
chr15:30921082-30921083 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs541744655 |
chr15:30921117-30921118 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs561617452 |
chr15:30921133-30921134 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs192078682 |
chr15:30921134-30921135 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs566433165 |
chr15:30921135-30921136 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs550341673 |
chr15:30921137-30921138 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs570181025 |
chr15:30921158-30921159 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs532506866 |
chr15:30921239-30921240 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs183974206 |
chr15:30921267-30921268 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs565958718 |
chr15:30921270-30921271 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs534979202 |
chr15:30921274-30921275 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs533797270 |
chr15:30921299-30921300 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs187774071 |
chr15:30921301-30921302 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs568748176 |
chr15:30921309-30921310 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs543910478 |
chr15:30921337-30921338 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs537686657 |
chr15:30921361-30921362 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs189678810 |
chr15:30921370-30921371 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs376887552 |
chr15:30921371-30921372 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs577327932 |
chr15:30921435-30921436 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs555358201 |
chr15:30921455-30921456 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs182080290 |
chr15:30921467-30921468 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs553004362 |
chr15:30921492-30921493 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs572767349 |
chr15:30921494-30921495 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs541412463 |
chr15:30921512-30921513 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs187034948 |
chr15:30921513-30921514 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs191573385 |
chr15:30921528-30921529 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs530713338 |
chr15:30921529-30921530 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs35981302 |
chr15:30921569-30921570 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs544059444 |
chr15:30921574-30921575 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs71397301 |
chr15:30921629-30921630 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs201797142 |
chr15:30921639-30921640 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs200360197 |
chr15:30921654-30921655 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs537830723 |
chr15:30921680-30921681 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs556654477 |
chr15:30921687-30921688 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs528523220 |
chr15:30921705-30921706 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs548597440 |
chr15:30921712-30921713 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs112354993 |
chr15:30921746-30921747 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs568809588 |
chr15:30921751-30921752 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|